Standard vs Mini-PCNL for the Treatment of Stone Disease
NCT ID: NCT04069013
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2022-05-01
2025-11-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MIP Versus PCNL for Kidney Stone Disease
NCT04767919
Comparison of Total Tubeless Mini-PCNL Versus Tubeless Mini-PCNL
NCT06288022
Mini-PCNL Versus Standard-PCNL For The Management of 20-40 mm Size Kidney Stones
NCT02635048
Mini-PNCL vs fURS in Management of Nephrolithiasis
NCT04389853
Standard-PCNL vs Mini-PCNL vs Super-mini PCNL for the Treatment of ≥2 cm Renal Stone
NCT03771365
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard PCNL
Patients receive a standard PCNL procedure using a 24 fr tract
PCNL
Patients receive standard of care treatment for their urolithiasis using one of two surgical procedures, either standard PCNL or Mini-PCNL
Mini-PCNL
Patients receive a mini-PCNL procedure using a 16 fr tract
PCNL
Patients receive standard of care treatment for their urolithiasis using one of two surgical procedures, either standard PCNL or Mini-PCNL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PCNL
Patients receive standard of care treatment for their urolithiasis using one of two surgical procedures, either standard PCNL or Mini-PCNL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years old
* Male and female patients
* Patients of all ethnic backgrounds
* Stone size 10-20mm
Patients must be capable of giving informed consent and must be capable and willing to enroll and participate fully with the study.
Exclusion Criteria
* Multiple access tracts
* Anticoagulated or history of coagulopathy
* Preoperative ureteral stent or nephrostomy tube placement
* Technical problems/impossibility of localizing the stone on the day of intervention
Patients unable to give informed consent or unwilling to enroll or participate in the study will be excluded.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Massachusetts General Hospital
OTHER
Vanderbilt University Medical Center
OTHER
Duke University
OTHER
Ohio State University
OTHER
Columbia University
OTHER
Dartmouth-Hitchcock Medical Center
OTHER
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manoj Monga, MD
Role: PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-589
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.